The markets opened flat with the Dow adding 9 points to 24,338 after an explosion at the Port Authority bus terminal. Nasdaq rose 7 points to 6,847.
On the upside
bluebird bio (Nasdaq: BLUE) reported positive updated data from an ongoing HGB-205 clinical study of LentiGlobin to treat severe sickle cell disease and transfusion-dependent B-thalassemia.
Pennsylvania selected CenturyLink (NYSE: CTL) as its network provider.
Bargain hunters lifted shares of Southwestern Energy (NYSE: SWN).
On the downside
Juno Therapeutics (Nasdaq: JUNO) and Celgene (Nasdaq: CELG) reported additional upbeat data from the TRANSCEND study of JCAR017 at dose level two but the stock price fell.
Seattle Genetics (Nasdaq: SGEN) presented data from a Phase 3 ECHELON-1 clinical trial of ADCETRIS to treat advanced Hodgkin lymphoma.
SCANA (NYSE: SCG) has proposed offering its failed nuclear reactor project at the Fairfield County site to South Carolina state utility Santee Cooper.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 added a point to 2,652. Bitcoin rocketed $1,890 to $16,150.